Figures
- Fig. 1—
Percentage of each institution by country. ▪: university hospital;
: non-university hospital; □: private institution; ▪: other; └: French Association. - Fig. 2—
Median (interquartile range) year of starting home mechanical ventilation (HMV) for each country. Denmark shows the median and full range as only two centres were included.
- Fig. 3—
Median (interquartile range) centre size for each country measured by number of home ventilation users. Denmark shows median only (range 250–253 for its two centres).
- Fig. 4—
Percentage of users in each disease category by country (see Methods section for an explanation of disease categories). ▪: lung/airways;
: thoracic cage; □: neuromuscular. - Fig. 5—
Duration of ventilation (number of yrs) by country. ▪: <1 yr;
: 1–5 yrs; □: 6–10 yrs; ▪: ≥11 yrs. - Fig. 6—
Percentage of pressure and volume preset positive pressure ventilators used by all home mechanical ventilation users by country. ▪: pressure preset;
: volume preset. - Fig. 7—
Percentage of nasal and facial masks and tracheostomies for each disease category by country for a) lung, b) thoracic and c) neuromuscular home mechanical ventilation (HMV) users. ▪: nasal mask;
: facial mask; □: tracheostomy. No data was available for Polish lung users.
Tables
- Table. 1—
Estimated number of centres, home mechanical ventilation users and prevalence#
Estimated Actual Response rate % Centres Users Prevalence¶ Centres Users Centres Users Austria 8 300 3.8 7 508 88 100+ Belgium 23 500 5 17 501 74 100 Denmark 2 500 9.6 2 503 100 100 Finland 20 450 8.7 16 121 80 27 France§ 50 10000 17 58 6338 100+ 63 Germany 54 5000 6.5 22 4220 41 84 Greece 12 70 0.6 5 122 42 100+ Ireland 15 155 3.4 14 155 93 100 Italy 70 2200 3.9 44 1928 63 88 Netherlands 4 900 5.6 9 918 100+ 100+ Norway 38 350 7.8 17 377 45 100+ Poland 8 40 0.1 17 46 100+ 100+ Portugal 39 933 9.3 20 801 51 86 Spain 35 2500 6.3 15 1400 43 56 Sweden 65 900 10 17 746 26 83 UK 40 2320 4.1 47 2842 100+ 100+ All countries 483 27118 6.6 329 21526 62 79 Data are presented as n, unless otherwise indicated. #: actual numbers in completed surveys and estimated percentage response rates; ¶: prevalence per 100,000 of the population; +: actual percentage response is >100%, but 100% used as maximum so as not to spuriously elevate the overall response rate; §: France's estimated number of centres includes the number of Associations plus known large prescribing hospitals.
